NDC 15631-0246

KALI ARSENICOSUM

Kali Arsenicosum

KALI ARSENICOSUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Potassium Arsenite Anhydrous.

Product ID15631-0246_6eb3145d-fc8b-47f0-abb8-6d1006e07a5f
NDC15631-0246
Product TypeHuman Otc Drug
Proprietary NameKALI ARSENICOSUM
Generic NameKali Arsenicosum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-09-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePOTASSIUM ARSENITE ANHYDROUS
Active Ingredient Strength6 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0246-0

100 PELLET in 1 PACKAGE (15631-0246-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0246-2 [15631024602]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0246-0 [15631024600]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0246-4 [15631024604]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0246-5 [15631024605]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0246-1 [15631024601]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0246-3 [15631024603]

KALI ARSENICOSUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM ARSENITE ANHYDROUS6 [hp_X]/1

OpenFDA Data

SPL SET ID:8d27282a-6393-49b4-8303-d0389efe9327
Manufacturer
UNII

NDC Crossover Matching brand name "KALI ARSENICOSUM" or generic name "Kali Arsenicosum"

NDCBrand NameGeneric Name
0220-2847Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
0220-2850Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
15631-0246KALI ARSENICOSUMKALI ARSENICOSUM
15631-0607KALI ARSENICOSUMKALI ARSENICOSUM
68428-448Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS
71919-377Kali arsenicosumPOTASSIUM ARSENITE ANHYDROUS

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.